U.S. Personal Products Stock News

NasdaqGS:AUGO
NasdaqGS:AUGOMetals and Mining

Why Aura Minerals (AUGO) Is Down 8.5% After Raising Borborema Reserves And Issuing 2026 Guidance

Aura Minerals Inc. recently reported 2025 results showing total sales of US$921.73 million and a net loss of US$79.34 million, alongside 278,296 gold equivalent ounces sold and a Board-approved dividend of US$0.66 per share (US$55.12 million in total) to be paid in March 2026. The company also released an updated Borborema feasibility study that lifted Probable Reserves to about 1.48 million ounces of gold, extended mine life to 20.5 years and supported stronger project economics, while...
NasdaqGS:GLUE
NasdaqGS:GLUEBiotechs

Assessing Monte Rosa Therapeutics (GLUE) Valuation After MRT-2359 Data, Phase 2 Plans And Capital Raise

Monte Rosa Therapeutics (GLUE) is back on investors’ radar after reporting encouraging Phase 1/2 data for MRT-2359 with enzalutamide in metastatic castration-resistant prostate cancer and outlining plans for Phase 2 trials along with a sizable equity raise. See our latest analysis for Monte Rosa Therapeutics. The latest MRT-2359 data and planned Phase 2 trials come after a strong run, with a year-to-date share price return of 16.26% and a 1-year total shareholder return of about 2x. At the...
NYSE:KKR
NYSE:KKRCapital Markets

The Bull Case For KKR (KKR) Could Change Following Charter Shift And Private-Credit Concerns – Learn Why

In recent weeks, KKR & Co. Inc. moved to amend its charter to eliminate supermajority voting requirements while also facing scrutiny over private-credit asset quality following a dividend cut at FS KKR Capital Corp. At the same time, KKR has pursued new growth avenues, including the planned acquisition of sports investor Arctos Partners and interest in a minority stake in IndiaRF-backed Synthimed Labs as it readies for an IPO, even as executives increased their personal shareholdings. We'll...
NYSE:KSS
NYSE:KSSMultiline Retail

Did Kohl’s Dividend and Turnaround Push Just Shift KSS’s Investment Narrative?

In February, Kohl’s Corporation’s board declared a regular quarterly dividend of US$0.125 per share, payable on April 1, 2026, to shareholders of record as of March 18, 2026. At the same time, investor attention has been building around Kohl’s upcoming earnings report and new leadership team, which some commentators see as a potential operational turning point. Next, we’ll examine how renewed focus on Kohl’s management-led turnaround and the upcoming earnings report could influence its...
NYSE:USPH
NYSE:USPHHealthcare

How Raised EBITDA Guidance, Record Volumes and Capital Moves At U.S. Physical Therapy (USPH) Have Changed Its Investment Story

In late February 2026, U.S. Physical Therapy reported fourth-quarter 2025 revenue of US$202.73 million and net income of US$4.15 million, announced a 10‑year alliance that will fold a subsidiary’s ten clinics into a local hospital’s network by year-end 2026, approved a quarterly dividend increase to US$0.46 per share effective for April 10, 2026, and disclosed an upcoming CFO transition with Jason Curtis stepping in on an interim basis. Alongside these updates, management raised full‑year...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Old National Bancorp (ONB) Valuation Check After Recent Share Price Pullback

Why Old National Bancorp Is On Investor Radars Today Old National Bancorp (ONB) has been catching attention after recent share price moves, with the stock down about 14% over the past month but roughly flat over the past 3 months. Against that backdrop, investors are looking more closely at how its current market valuation lines up with reported annual revenue of US$2.3b and net income of US$653.1 million, along with its value score of 4. See our latest analysis for Old National Bancorp. At a...
NYSE:EHC
NYSE:EHCHealthcare

A Look At Encompass Health’s Valuation As It Opens A New Rehabilitation Hospital In South Carolina

Business expansion in South Carolina Encompass Health (EHC) has opened the Encompass Health Rehabilitation Hospital of Irmo, a 49 bed inpatient facility in South Carolina, expanding its regional rehabilitation footprint and adding capacity across several complex care needs. See our latest analysis for Encompass Health. Against this backdrop, Encompass Health’s 1 year total shareholder return of 8.6% and 3 year total shareholder return of around 7x, alongside a modest year to date share price...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Astronics (ATRO) Is Down 5.7% After Profitability Turnaround And Higher 2026 Guidance Has The Bull Case Changed?

Astronics Corporation recently reported past fourth-quarter 2025 sales of US$240.07 million, up from US$208.54 million a year earlier, with net income improving to US$29.62 million from a prior net loss and earnings per share swinging from a loss to a profit. For full-year 2025, Astronics moved from a net loss to US$29.36 million in net income on higher sales of US$862.13 million, and paired this turnaround with 2026 revenue guidance of US$950 million to US$990 million, signaling...
NYSE:TXNM
NYSE:TXNMElectric Utilities

A Look At TXNM Energy (TXNM) Valuation After Its Rebrand And Conflicting Fair Value Signals

TXNM Energy (TXNM) is on investors’ radar after its recent rebrand from PNM Resources, shifting its identity while continuing to provide regulated electricity and related services across Texas and New Mexico. See our latest analysis for TXNM Energy. The share price has held close to US$58.88 in recent weeks, with a modest 90 day share price return of 1.08% contrasting with a stronger 1 year total shareholder return of 26.63%. This suggests longer term momentum remains intact despite quieter...
NYSE:RYAN
NYSE:RYANInsurance

A Look At Ryan Specialty Holdings (RYAN) Valuation After Revenue Growth Acquisitions And The Empower Program

Ryan Specialty Holdings (RYAN) is back in focus after reporting 2025 revenue of more than US$3.05b, completing five acquisitions, and launching its three year Empower Program to streamline operations and cut costs. See our latest analysis for Ryan Specialty Holdings. Despite the Empower Program and recent acquisitions getting attention, Ryan Specialty Holdings’ 1 day share price return of 1% and 7 day share price return of 0.9% sit against a 30 day share price decline of 16.4%, a year to date...
NasdaqGS:BELF.A
NasdaqGS:BELF.AElectronic

Is It Time To Reassess Bel Fuse (BELF.A) After The Recent Share Price Pullback

If you are wondering whether Bel Fuse shares still offer value after a strong run, this article explains what the current price might be implying about the business. The stock closed at US$172.94 recently, with a 7 day return of an 18.4% decline and a 30 day return of a 16.0% decline, while the 1 year return sits at 119.7% and the 3 year return is very large. These price moves sit against a backdrop of ongoing attention on Bel Fuse within the tech sector, as investors reassess companies that...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Is Bio-Techne (TECH) Now More a Macro Sentiment Story Than a Healthcare Innovation Play?

Bio-Techne recently presented at the TD Cowen 46th Annual Health Care Conference on March 3, 2026, at the Boston Marriott Copley Place Hotel in Boston, Massachusetts, sharing its latest updates with investors and industry participants. This conference appearance came shortly after broader healthcare sector concerns tied to a weak February jobs report, linking Bio-Techne’s story more closely to macroeconomic sentiment than to company-specific developments. We’ll now examine how sector-wide...
NYSE:MRP
NYSE:MRPSpecialized REITs

Is Millrose Properties (MRP) Now Attractive After Recent REIT Portfolio Coverage And Price Pullback

If you are wondering whether Millrose Properties at around US$29.77 is offering genuine value or just looks cheap on the surface, you are not alone. The stock has pulled back with a 4.0% decline over the past week and a 6.1% decline over the past month, yet it still sits on a 50.2% return over the last year and is close to flat year to date at a 0.2% decline. Recent news around Millrose has focused on its position as a listed real estate player, including ongoing coverage of its portfolio...
NYSE:EOG
NYSE:EOGOil and Gas

Why EOG Resources (EOG) Is Up 5.9% After Mixed 2025 Results And Maintained Dividend Guidance

In February 2026, EOG Resources reported fourth-quarter and full-year 2025 results showing revenue of US$5,638 million for the quarter and US$22.63 billion for the year, alongside lower net income, and declared a US$1.02 per-share dividend payable on April 30, 2026. The company paired softer earnings with meaningfully higher oil and gas production volumes and detailed 2026 output guidance, giving investors a clearer view of its operating profile and capital returns priorities. Next, we will...
NYSE:CTRA
NYSE:CTRAOil and Gas

Assessing Coterra Energy (CTRA) Valuation After Strong Results Guidance And Dividend Confirmation

Earnings, production and dividend decisions in focus Coterra Energy (CTRA) has drawn fresh attention after fourth quarter and full year 2025 results, new 2026 production guidance and a quarterly dividend affirmation combined with supportive views from several research firms. See our latest analysis for Coterra Energy. Coterra’s shares trade at US$31.03, with a 90 day share price return of 16.79% and a 1 year total shareholder return of 23.11%. This suggests momentum has picked up recently...
NasdaqGS:MSTR
NasdaqGS:MSTRSoftware

Assessing Strategy’s Valuation After Fresh Bitcoin Buy And Policy Tailwinds

Strategy (MSTR) is back in focus after Bitcoin touched a one month high. The company added 3,015 bitcoins, lifting its holdings above 720,000 BTC and benefiting from friendlier US crypto policy signals. See our latest analysis for Strategy. Despite the latest Bitcoin-driven bounce and friendlier policy signals, Strategy’s recent momentum has been weak, with a 90 day share price return showing a 29.35% decline and a 1 year total shareholder return of a 44.19% loss, contrasting with a very...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu’s Kunlunxin IPO Plans Put AI Chip Value in Focus

Baidu's AI chip unit Kunlunxin is preparing for an IPO expected to be completed by the first half of 2026. The planned listing could allow Kunlunxin to be included in Southbound Trading of Stock Connects after the IPO. The move highlights Baidu's focus on AI hardware alongside its core internet and AI services business. For investors following NasdaqGS:BIDU, Kunlunxin sits at the intersection of Baidu's AI research and the growing demand for specialized chips. The subsidiary focuses on AI...
NYSE:VICI
NYSE:VICISpecialized REITs

Assessing VICI Properties (VICI) Valuation After Recent Share Price Momentum Picks Up

Why VICI Properties Is On Investors’ Radar VICI Properties (VICI) has drawn fresh attention after recent share moves, with the stock showing mixed returns over the past year and a modest gain over the past 3 months. See our latest analysis for VICI Properties. At a share price of $29.67, VICI’s recent 30-day share price return of 3.16% and 90-day share price return of 6.88% sit against a 1-year total shareholder return of 3.78% decline. This suggests momentum has been picking up after a...
NYSE:SHAK
NYSE:SHAKHospitality

How Strong 2025 Earnings and CEO Conference Appearance Could Shape Shake Shack (SHAK) Investors’ Outlook

Shake Shack Inc. recently reported fourth-quarter 2025 revenue of US$400.53 million and net income of US$11.83 million, alongside full-year 2025 revenue of US$1.45 billion and net income of US$45.73 million, and its CEO is set to present at Loop's 7th Annual Investor Conference 2026 in New York. The combination of strong year-on-year improvements in earnings per share and upcoming investor conference commentary offers investors fresh insight into how Shake Shack is managing growth, costs,...
NYSE:SOC
NYSE:SOCOil and Gas

Sable Offshore (SOC) Is Up 74.2% After DOJ Opinion Opens Door To Override California Curbs

Sable Offshore Corp. recently reported its full-year 2025 results, recording a net loss of US$410.16 million, while its auditor issued an unqualified opinion that raised doubt about the company’s ability to continue as a going concern. At the same time, a Department of Justice Office of Legal Counsel opinion indicated that a presidential order under the Defense Production Act could override California laws restricting Sable Offshore’s key California pipeline and offshore operations,...
NYSE:F
NYSE:FAuto

Ford Resets SK On Battery Deal And Refines EV Investment Path

Ford Motor (NYSE:F) and battery partner SK On are dissolving their U.S. joint venture focused on electric vehicle batteries. SK On will assume full control of the Tennessee battery plant, while Ford will take ownership of the Kentucky battery plants. The restructuring includes workforce reductions at the Tennessee facility as the partnership terms are unwound. For you as an investor looking at NYSE:F, this shift is part of Ford's push into electric vehicles and its need for reliable battery...
NasdaqGS:CVLT
NasdaqGS:CVLTSoftware

Does Commvault’s Identity-Centric Cyber Resilience Push Reframe the Bull Case For CVLT?

In recent weeks, Commvault Systems has expanded its cyber resilience portfolio by adding Okta support, deepening integrations with CrowdStrike and CloudSEK, and partnering with European sovereign cloud provider STACKIT to enhance secure, immutable data protection and identity recovery capabilities. By tying together identity recovery, dark web credential intelligence, SIEM visibility, and EU-sovereign cloud storage, Commvault is positioning its platform more squarely at the intersection of...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

Assessing BioMarin Pharmaceutical (BMRN) Valuation After FDA Expands PALYNZIQ Label For Pediatric PKU

BioMarin Pharmaceutical (BMRN) is back in focus after the FDA approved a supplemental Biologics License Application for PALYNZIQ, expanding treatment eligibility to pediatric phenylketonuria patients aged 12 and older. See our latest analysis for BioMarin Pharmaceutical. The PALYNZIQ approval lands after a stretch where BioMarin’s share price has shown improving momentum, with a 13.73% 90 day share price return and a 5.14% 30 day share price return, even though the 1 year total shareholder...
NasdaqGS:MGRC
NasdaqGS:MGRCTrade Distributors

McGrath RentCorp’s 2026 Guidance and Dividend Hike Might Change The Case For Investing In MGRC

In late February 2026, McGrath RentCorp reported fourth-quarter and full-year 2025 results, issued full-year 2026 revenue guidance of US$945 million to US$995 million, and declared a quarterly cash dividend of US$0.495 per share payable on April 30, 2026. While full-year net income declined compared with 2024, the combination of higher quarterly earnings, continued revenue growth and a 2% dividend increase highlighted management’s confidence in the business and its cash-generation...